LIP
VKTX icon

Lighthouse Investment Partners’s Viking Therapeutics VKTX Stock Holding History

Lighthouse Investment Partners’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,500
Closed -$615K – 546
2024
Q1 		$615K Buy
+7,500
New +$334K 0.03% 315

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Lighthouse Investment Partners's VKTX Position: Q2 2026 in Review

Lighthouse Investment Partners opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 36,140 shares worth $1.41M. The stake represents 0.04% of the portfolio and ranks #420 among its holdings. This is a return to the name: Lighthouse Investment Partners previously reported a position in VKTX as recently as Q1 2024.

Lighthouse Investment Partners first reported a position in VKTX in Q4 2022 and has held it in 3 quarters since. The position peaked at $2.53M in Q1 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Lighthouse Investment Partners held 36,140 shares of Viking Therapeutics worth $1.41M as of Q2 2026.
  • Viking Therapeutics was a new Lighthouse Investment Partners position in Q2 2026.
  • Viking Therapeutics made up 0.04% of Lighthouse Investment Partners's portfolio in Q2 2026, its #420 holding.
  • Lighthouse Investment Partners first reported a position in Viking Therapeutics in Q4 2022 and has held it in 3 quarters since.
  • Lighthouse Investment Partners's Viking Therapeutics position peaked at $2.53M in Q1 2024.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.